MS
Mateusz Solski
Ceased PSC Person with significant control at SYNTHAGEN PHARMACEUTICAL LTD
Notified on 20th Aug 2024 · Ceased on 13th Dec 2025
Mateusz Solski
Reports & checks
Buy a company report
Run an identity check
Natures of control
- Ownership of shares 25 to 50 percent
- Voting rights 25 to 50 percent
- Right to appoint and remove directors